okyopharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | OKYO |
| Description | GPCR Technology Platform: A novel approach to develop innovative therapies for inflammatory eye About Us Disease Focus Dry Eye Disease Non-infectious Anterior Uveitis Allergic Conjunctivitis Chronic Pain --> Ocular Pain Technology R&D Pipeline Inv |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 98.129.229.62 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
okyopharma.com Valuation
|
US$4,000,706
Last updated: 2022-06-23 09:24:05
okyopharma.com has Semrush global rank of 2,645,609. okyopharma.com has an estimated worth of US$ 4,000,706, based on its estimated Ads revenue. okyopharma.com receives approximately 461,620 unique visitors each day. Its web server is located in United States, with IP address 98.129.229.62. According to SiteAdvisor, okyopharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,000,706 |
| Daily Ads Revenue | US$3,693 |
| Monthly Ads Revenue | US$110,789 |
| Yearly Ads Revenue | US$1,329,466 |
| Daily Unique Visitors | 30,775 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| okyopharma.com. | A | 600 | IP: 98.129.229.62 |
| okyopharma.com. | NS | 3600 | NS Record: ns54.domaincontrol.com. |
| okyopharma.com. | NS | 3600 | NS Record: ns53.domaincontrol.com. |
| okyopharma.com. | MX | 3600 | MX Record: 0 okyopharma-com.mail.protection.outlook.com. |
| okyopharma.com. | TXT | 3600 | TXT Record: MS=ms47483359 |
| okyopharma.com. | TXT | 3600 | TXT Record: v=verifydomain MS=2431020 |
| okyopharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-06-23 09:24:05
| About Us Disease Focus Dry Eye Disease Non-infectious Anterior Uveitis Allergic Conjunctivitis Chronic Pain --> Ocular Pain Technology R&D Pipeline Investor Relations Share Information Shareholder Services Investor Updates Corporate Governance Corporate Information Corporate Documents Corporate Directory News Contact Us GPCR Technology Platform: A novel approach to develop innovative therapies for inflammatory eye diseases and ocular pain management Learn more Our Mission OKYO focuses on novel GPCR based therapeutics for eye diseases of high unmet need and non-opioid analgesics for chronic ocular pain, where large market potential exists. Specifically, OKYO is developing first-in-class drug candidates for the treatment of dry-eye, uveitis, acute and chronic ocular pain. Our Focus A novel class of membrane-anchored Chemerin receptor GPCR agonist that targets the inflammatory pathways to treat dry eye syndrome, uveitis and allergic conjunctivitis Learn more An agonist for MAS-Related |
HTTP Headers
HTTP/1.1 302 Found Server: Apache/2.4 Content-Type: text/html; charset=iso-8859-1 Date: Sun, 24 Oct 2021 09:11:09 GMT Location: https://www.okyopharma.com/ Transfer-Encoding: chunked Connection: Keep-Alive Set-Cookie: X-Mapping-jppjiboj=2CBC175A52E4E64A22F5697115586BE5; path=/ HTTP/1.1 200 OK server: Apache/2.4 content-type: text/html; charset=UTF-8 date: Sun, 24 Oct 2021 09:11:09 GMT x-xss-protection: 1; mode=block transfer-encoding: chunked x-content-type-options: nosniff set-cookie: X-Mapping-jppjiboj=2CBC175A52E4E64A22F5697115586BE5; path=/ x-frame-options: deny |
okyopharma.com Whois Information
Domain Name: OKYOPHARMA.COM Registry Domain ID: 2201476796_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-03-16T14:37:27Z Creation Date: 2017-12-18T16:24:52Z Registry Expiry Date: 2022-12-18T16:24:52Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS53.DOMAINCONTROL.COM Name Server: NS54.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T17:13:17Z <<< |